Fatty acid metabolism suppresses neonatal cardiomyocyte proliferation by increasing PDK4 and HMGCS2 expression

Shota Tanaka1, Akane Hirota1, Yoshiaki Okada1

  • 1Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Plos One
|May 8, 2025
PubMed

Insights

Fatty acid metabolism, regulated by pyruvate dehydrogenase kinase 4 (PDK4) and HMG-CoA synthase 2 (HMGCS2) via PPARδ, suppresses neonatal cardiomyocyte proliferation and cell cycle activity.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Biology

Background:

  • Cardiomyocytes lose regenerative capacity post-birth, shifting metabolism to fatty acid oxidation.
  • Fatty acid metabolism is implicated in suppressing cardiomyocyte proliferation, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms by which fatty acid metabolism regulates cell cycle in neonatal cardiomyocytes.
  • To elucidate the role of PDK4 and HMGCS2 in fatty acid-induced suppression of cardiomyocyte proliferation.

Main Methods:

  • Neonatal rat cardiomyocytes (NRCMs) were cultured and treated with fatty acids (FA), PPARδ activator (GW501516), or PPARδ inhibitor (GSK3787).
  • Gene expression of β-oxidation enzymes, PDK4, and HMGCS2 was analyzed.
  • Cell proliferation was assessed by Ki67 staining.
  • Overexpression and silencing of PDK4 and HMGCS2 were performed using lentiviral vectors.

Main Results:

  • FA treatment increased β-oxidation enzymes, PDK4, and HMGCS2, while reducing Ki67-positive NRCMs.
  • PPARδ activation upregulated fatty acid metabolism and inhibited NRCM proliferation; PPARδ inhibition reversed these effects.
  • Overexpression of PDK4 or HMGCS2 suppressed NRCM cell cycle activity.
  • Silencing PDK4 or HMGCS2 restored cell cycle progression even under FA-rich conditions.

Conclusions:

  • Fatty acid metabolism, mediated by PPARδ activation, increases PDK4 and HMGCS2 expression.
  • Elevated PDK4 and HMGCS2 suppress neonatal cardiomyocyte proliferation by inhibiting cell cycle activity.
  • Targeting fatty acid metabolism pathways may offer strategies to enhance cardiac regeneration.